1. Home
  2. IMKTA vs RAPT Comparison

IMKTA vs RAPT Comparison

Compare IMKTA & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

HOLD

Current Price

$85.91

Market Cap

1.6B

ML Signal

HOLD

Logo RAPT Therapeutics Inc.

RAPT

RAPT Therapeutics Inc.

HOLD

Current Price

$57.99

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMKTA
RAPT
Founded
1963
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
IMKTA
RAPT
Price
$85.91
$57.99
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$56.22
AVG Volume (30 Days)
129.2K
4.6M
Earning Date
05-06-2026
01-01-0001
Dividend Yield
0.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,334,032,609.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.09
$0.71
52 Week High
$90.49
$58.02

Technical Indicators

Market Signals
Indicator
IMKTA
RAPT
Relative Strength Index (RSI) 58.95 78.57
Support Level $68.58 $32.00
Resistance Level $90.24 N/A
Average True Range (ATR) 2.65 0.09
MACD -0.66 -0.79
Stochastic Oscillator 25.53 90.91

Price Performance

Historical Comparison
IMKTA
RAPT

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Share on Social Networks: